Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

2cureX Q4: Comments on the report

2021-02-26

09:18

OB

Oscar Bergman

Redeye gives its comments on the Q4 report published by 2cureX yesterday evening. Most important during the quarter was the finalized patient enrolment for its colorectal cancer study, which we expect to see results from relatively shortly.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers